In addition, a β1‐AR blocker (nebivolol) specifically impeded oxidative phosphorylation in cancer cells, preventing tumor angiogenesis by blocking endothelial cell proliferation and limiting colon and breast cancer growth.25 This evidence concerns the gene ADRB1 and breast carcinoma.